Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Eugene Podrez, MD, PhD

No Patient Satisfaction Reviews
Eugene Podrez, MD, PhD
Department: Molecular Cardiology
Location: Cleveland Clinic Main Campus
Mail Code NB50
9500 Euclid Avenue
Cleveland, OH 44195
Type of Doctor:

Biographical Sketch

Eugene A. Podrez, MD, PhD, is a member of Assistant Staff at Cleveland Clinic, and an Assistant Professor in Cleveland Clinic's Lerner College of Medicine of Case Western Reserve University. From 2001 to 2004, Dr. Podrez acted as Project Scientist in the Department of Cell Biology at Cleveland Clinic's Lerner Research Institute. He served as Postdoctoral Fellow and Research Associate from 1999 to 2001.

Dr. Podrez received his MD degree in 1982 from Moscow Medical University, Russia, and his PhD in cardiology  in 1989 from the National Cardiology Research Center, Moscow. As a postgraduate student, he received additional training in cell biology and biochemistry at the National Cardiology Research Center, Moscow, from 1982 to 1984. He served as Junior Research Scientist, Research Scientist and then Senior Research Scientist at that institution from 1984 to 1994.

Awards & Honors

Robert C. Tarazi Fellowship Award for cardiovascular research, Cleveland Clinic, 1999  

“Pathophysiological Activities of Oxidized Phospholipids,” NIH/NHLBI Grant RO1HL077213-01 A1, E.A. Podrez, Principle Investigator ($1,000,000/5-year direct costs), 2005-2010 

“Molecular Basis of Oxidative Modification of LDL,” NIH /NHLBI Grant 5R01HL053315-07, E.A. Podrez, Co-Investigator (total direct costs - $1,500,000/5-year; 500,000/5-year direct costs to E.A.Podrez), 2005-2010


  • Council on Arteriosclerosis, Thrombosis and Vascular Biology, American Heart Association

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/9/2016, Dr. Podrez has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Russian